»È¦æªÑ±a°Ê¤É¥« ¹D«ü¼Ð´¶³Ð·s°ª
¡i©ú³ø±M°T¡jµØº¸µó¼Ð´¶500«ü¼Æ»P¹Dã´µ«ü¼Æ©P¤G¦¬¥«³Ð·s°ª¬ö¿ý¡A»È¦æªÑ±a°ÊªÑ¥«¡A§ë¸êªÌ±K¤Á¯d·N¡A¬ü°ê¬F©²¥i¯à°§C¥ø·~µ|¡A±j«l³qµÈ¼Æ¾Ú¤Ï¬M¸gÀÙ«ùÄò¼Wªø¡C
ÀHµÛªo»ù‘C¤É¡B¨ä¥L³fª«¦¨¥»¤W¤É¡Aªñ6¦~¨Ó³Ì¤jªº«ö¦~¼Wªø¡A¬ü°ê¥Í²£»ù®æ«ü¼Æ¦b11¤ëÃk¤É¡C
§ë¸êªÌ§Æ±æ¡A¬ü°ê¦@©MÄÒ§¹¦¨µ|°È§ï²³Ì«áªk®×¡A¹w®Æ·|«d´î¥ø·~µ|²v¡C
¯Ã¬ùKeefe, Bruyette & Woods¥æ©ö¥DºÞ®æÄõ¯S(RJ Grant)ªí¥Ü¡G¡uµ|ªk§Ö¨ì²×ÂI¡AÁÙ¦³¸û¬°±j«lªº¥þ²y¸gÀټƾڡA¦h¼Æ¬Ýªk¼ÖÆ[¡C¡v
³Ì²r±À¤O¨Ó¦Ûª÷¿Ä·~.SPSY¡A¤W¤É1%¡Q¨ä¦¸¬OÂåÀøÅ@²zªÑ.SPXHC¡A¼W¥[0.41%¡C¹q°T«ü¼Æ.SPLRCL¦³³Ì¤j¦Ê¤À¤ñ¤É´T¡AÃk¤É¤F2.8%¡C
¯Ã¬ù¹Dã´µ¤u·~¥§¡«ü¼Æ¬P´Á¤G¦¬¥«³ø24,504.80ÂI¡A¤W¤É118.77ÂI¡C¼Ð·Ç´¶º¸500«ü¼Æ¤W¤É4.12ÂI¡A¨ì2,664.11ÂI¡C¯Ç´µ¹F§Jºî¦X«ü¼Æ¤U¶^12.76ÂI¡A¨ì6,862.32ÂI¡C
¥[®³¤j¥Dn«ü¼Æ¤W´¡A±a¤É¬É§OÂåÀøÅ@²z·~¡C¦hÛ¦hÃÒ¨é¥æ©ö©Ò¼Ð´¶ºî¦X«ü¼Æ¤W¤É10.52ÂI¡A¨ì16,114.03ÂI¡C»sÃÄ¥¨À¼Valeant Pharmaceuticals International Inc.(¥N¸¹VRX)Ãk¤É¡A©P¤G¦¬³ø¬ù¦³7%¤É´T¡C